NPPB and myocardial infarction: The NT-proBNP concentrations fell in both the empagliflozin group and the control group in the EMMY/EMBODY research, which looked at how empagliflozin medication affected post-MI sympathomimetic activity [3,8]. In terms of prognostic indicators like the risk of sudden cardiac death and overall mortality, it has been shown that LVEF recovery in the weeks after a myocardial infarction is preferable to baseline LVEF alone [24,25].